Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?
- 194 Downloads
We hypothesized that ejection fraction (EF) best predicts cardiovascular death but only measures of ischemia predict relative survival benefit from revascularization compared with medical therapy.
Methods and Result
We followed up 5366 consecutive patients without prior revascularization who underwent stress electrocardiography-gated myocardial perfusion single photon emission computed tomography (MPS) for 2.8 ± 1.2 years, during which 146 cardiac deaths occurred (2.7%, 1.0%/y). The treatment received within 60 days after MPS was used to define the subgroups (revascularization in 402 patients, with cardiac death occurring in 6.2%, vs medical therapy in 4964 patients, with cardiac death occurring in 2.4%; P < .0001, χ2 = 18.7). Adjustment for nonrandomized treatment assignment used a propensity score based on logistic regression modeling of referral to revascularization. The percent of myocardium that was ischemic was the most important predictor of revascularization. The overall model (multivariate χ2 = 728, c index = 0.89, P < 10-5) was used as a propensity score. Cox proportional hazards analysis, assessing the relationship between MPS results, non-MPS covariates, and cardiac death, revealed that EF was superior to percent ischemic myocardium in the prediction of cardiac death after adjustment for pre-MPS data and the propensity score. However, an interaction between percent ischemic myocardium and revascularization was present such that, irrespective of EF, patients with little or no ischemia had an improved survival rate with medical therapy, whereas with increasing ischemia, progressive improvements in survival rate were noted with revascularization.
Although EF predicts cardiac death, only inducible ischemia identifies which patients have a short-term benefit from revascularization.
Key WordsTechnetium 99m sestamibi single photon emission computed tomography myocardial perfusion prognosis outcomes
Unable to display preview. Download preview PDF.
- 1.Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.PubMedCrossRefGoogle Scholar
- 2.Berman DS, Hachamovitch R, Shaw LJ, Germano G, Hayes S. Nuclear cardiology. In: Fuster V, Alexander R, King S, O’Rourke RA, Wellens HJJ, editors. Hurst’s the heart. New York: McGraw-Hill; 2004. p. 525–65.Google Scholar
- 3.Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Identification of a threshold of inducible ischemia associated with a short-term survival benefit with revascularization compared to medical therapy in patients with no prior CAD undergoing stress myocardial perfusion SPECT. Circulation 2003;107:2899–906.CrossRefGoogle Scholar
- 6.Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–64.PubMedGoogle Scholar
- 8.Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–47.PubMedCrossRefGoogle Scholar
- 20.Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York:Wiley; 1989.Google Scholar
- 22.Harrell FJ. Predicting outcomes: applied survival analysis and logistic regression. Charlottesville: University of Virginia; 2000.Google Scholar
- 23.Cox D. Regression models and life tables (with discussion). J R Stat Soc Ser B 1972;34:187–220.Google Scholar
- 25.Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563–70.PubMedCrossRefGoogle Scholar
- 27.Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Fisher LD, et al. Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in three-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1987;60:262–6.PubMedCrossRefGoogle Scholar